Histological and Imaging Assessment of the Structural Characteristics of the Femoro-popliteal Arterial Segment
NCT ID: NCT03847597
Last Updated: 2019-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2019-04-30
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, the structural features of the atherosclerotic disease in regards to patient's risk factors and past medical and surgical histories are not well studied. Furthermore, the histological analysis of the femoro-popliteal arterial segment is rare in the literature, and made difficult mostly because of the length of this segment.
There is a clinical need for better understanding of atherosclerotic lesions in this location, with as further goal, a better management of this disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vessel Deformations and Restenosis After Stenting of the Popliteal Artery
NCT04700371
Safety and Efficacy of Atherectomy on VasculaR Functions
NCT04092972
Outcomes of Endovascular Treatment of Superficial Femoral Artery In-stent Restenosis
NCT04123639
Behavior of the Iliofemoral Segment
NCT06113172
The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease
NCT05057637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Explantation of the femoro-popliteal arterial segment from the amputed limb
Explantation of the femoro-popliteal arterial segment from the amputed limb
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women
* Patient with chronic limb ischemia that is scheduled for transfemoral amputation in the University Hospital of Strasbourg
* Patient giving his -non-opposition to the explantation and use of the femoro-popliteal arterial segment
Exclusion Criteria
* Impossibility to give clear information to the patient
* Pregnant and breastfeeding women
* Patient under administrative protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nabil CHAKFE
Role: PRINCIPAL_INVESTIGATOR
Les Hôpitaux Universitaires de Strasbourg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7168
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.